Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators
- 17 March 2000
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 448 (2), 139-151
- https://doi.org/10.1016/s0027-5107(99)00232-8
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdeltaGenes & Development, 1999
- Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activatorsNature, 1998
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996
- Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms.Proceedings of the National Academy of Sciences, 1995
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectible foci in rat liverToxicology, 1989
- Biochemical Mechanisms of Induction of Hepatic Peroxisome ProliferationAnnual Review of Pharmacology and Toxicology, 1989
- Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesisCancer Letters, 1989
- Peroxisome proliterators and cancer: mechanisms and implicationsTrends in Pharmacological Sciences, 1986
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980